High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas

Journal of Clinical Pathology

Volumn 65, Issue 11, 2012, Pages 1019-1023

  Yanagisawa, Nobuyuki ^a,b   Ichinoe, Masaaki ^a,b   Mikami, Tetuo ^a,b   Nakada, Norihiro ^a,b   Hana, Kiyomi ^a,c   Koizumi, Wasaburo ^a   Endou, Hitoshi ^c,d   Okayasu, Isao ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c J Pharma Co   (Japan)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; KI 67 ANTIGEN; L TYPE AMINO ACID TRANSPORTER 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; COLLOID CARCINOMA; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84867904232     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200826     Document Type: Article

References (21)

1. Carpelan-Holmstrom M, Nordling S, Pukkala E, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005;54:385-7. (Pubitemid 40299095)
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Kanai Y, Segawa H, Miyamoto K, et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998;273:23629-32. (Pubitemid 28435687)
4. Sakata T, Ferdous G, Tsuruta T, et al. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol Int 2009;59:7-18.
5. Kobayashi H, Ishii Y, Takayama T. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol 2005;90:233-8. (Pubitemid 40770938)
6. Kaira K, Oriuchi N, Imai H, et al. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer 2009;66:120-6.
7. Ichinoe M, Mikami T, Yoshida T, et al. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol Int 2011;61:281-9.
8. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. Lyon: IARC, 2010.
9. Sobin L, Gospodarowicz MK, Wittekind C. UICC;TNM classification of malignant tumors. 7th edn. Oxford: Wiley-Blackwell, 2009:133-5.
10. Sinicrope FA, Ruan SB, Cleary KR, et al. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41.
11. Jeong S, Lee DH, Lee JI, et al. Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma. World J Gastroenterol 2005;11:6765-9. (Pubitemid 43092445)
12. Sagol O, Yavuzsen T, Oztop I, et al. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma. Pancreas 2005;30:343-8. (Pubitemid 40586813)
13. Yanagida O, Kanai Y, Chairoungdua A, et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001;1514:291-302. (Pubitemid 32831016)
14. Pineda M, Fernandez E, Torrents D, et al. Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 1999;274:19738-44.
15. Oda K, Hosoda N, Endo H, et al. L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci 2009;101:173-9.
16. Imai H, Kaira K, Oriuchi N, et al. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res 2010;30:4819-28.
17. Mayo SC, Nathan H, Cameron JL, et al. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer 2012;118:2674-81.
18. Ferrara C, Tessari G, Poletti A, et al. Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker? Oncol Rep 1999;6:1117-22.
19. Garcea G, Neal CP, Pattenden CJ, et al. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005;41:2213-36. (Pubitemid 41415597)
20. Tonini G, Pantano F, Vincenzi B, et al. Molecular prognostic factors in patients with pancreatic cancer. Expert Opin Ther Targets 2007;11:1553-69. (Pubitemid 350285005)
21. Imai H, Kaira K, Oriuchi N, et al. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology 2009;54:804-13.